Superdisintegrants Global Market Report 2025

The superdisintegrants market size has grown strongly in recent years. It will grow from $1.09 billion in 2024 to $1.16 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be credited to the increasing prevalence of chronic and lifestyle-related diseases, the expansion of the global pharmaceutical industry, the rising demand for orally disintegrating tablets (ODTs), the growing geriatric and pediatric populations, and the heightened focus on enhancing drug bioavailability.

The superdisintegrants market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth during the forecast period can be credited to the increasing demand for oral solid dosage forms, the rising prevalence of chronic diseases, the expansion of pharmaceutical manufacturing, and the growing need for effective drug delivery solutions. Key trends in the forecast period include the integration of technology in manufacturing, advancements in co-processed excipients, a shift toward natural and biodegradable superdisintegrants, the development of innovative drug-delivery systems, and enhanced collaboration between excipient manufacturers and pharmaceutical companies.

The increasing production of generic drugs is expected to drive the growth of the superdisintegrants market. Generic drugs contain the same active ingredients, dosage, strength, route of administration, quality, and performance as brand-name drugs but are generally available at a lower cost. The rising production of generic drugs is fueled by the growing demand for affordable medications, the expiration of patents for branded drugs, and government initiatives aimed at reducing healthcare costs. Superdisintegrants play a crucial role in generic drug formulations by enhancing tablet disintegration and dissolution, leading to faster drug release, improved bioavailability, and better patient compliance. For example, in January 2023, the Food and Drug Administration (FDA), a US-based government agency, reported that in 2022, approximately 91% of prescriptions in the United States were filled with generic drugs, with over 32,000 generic medications having been approved by the FDA to date. As a result, the increasing production of generic drugs is contributing to the expansion of the superdisintegrants market.

Key companies in the superdisintegrants market are focusing on innovative solutions, such as multifunctional disintegrants, to enhance drug formulation efficiency, accelerate tablet disintegration, and improve patient compliance in pharmaceutical applications. Multifunctional disintegrants are advanced excipients that combine disintegration, binding, and flow-enhancing properties to optimize tablet formulation efficiency and drug release. For instance, in June 2023, Ashland Inc., a US-based chemicals company, introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant designed to improve tablet disintegration, powder flow, and lubrication during pharmaceutical manufacturing. This innovation streamlines production by eliminating two manufacturing steps, enhancing tablet hardness, and supporting high-speed and continuous manufacturing processes.

In April 2023, Ingredion Inc., a US-based food company, acquired Amishi Drugs & Chemicals Private Limited for an undisclosed amount. Through this acquisition, Ingredion aims to expand its portfolio of specialty pharmaceutical products, strengthen its expertise in functional excipients, establish a stronger presence in the rapidly growing Indian pharmaceutical market, and support global exports with high-quality, pharma-grade ingredients. Amishi Drugs & Chemicals Private Limited is an India-based company specializing in the production of superdisintegrants for enhanced tablet disintegration and drug formulation.

Major players in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., and JH Nanhang Life Sciences Co. Ltd.

North America was the largest region in the superdisintegrants market in 2024. The regions covered in superdisintegrants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the superdisintegrants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Superdisintegrants are pharmaceutical excipients specifically formulated to accelerate the disintegration of tablets or capsules, enabling faster release and absorption of the active pharmaceutical ingredient (API) in the body. They are essential for enhancing drug bioavailability and ensuring efficacy, particularly in orally administered medications.

The primary categories of superdisintegrants include natural, synthetic, and other types. Natural superdisintegrants are plant-based or naturally derived substances that aid in the breakdown of tablets within the gastrointestinal tract, improving drug dissolution and absorption. These excipients are used in various formulations, such as tablets and capsules, and play a vital role in treating a range of therapeutic areas, including gastrointestinal diseases, neurological disorders, oncology, infectious diseases, cardiovascular conditions, and hematological diseases.

The superdisintegrants market research report is one of a series of new reports that provides superdisintegrants market statistics, including the superdisintegrants industry global market size, regional shares, competitors with the superdisintegrants market share, detailed superdisintegrants market segments, market trends, and opportunities, and any further data you may need to thrive in the superdisintegrants industry. This superdisintegrants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The superdisintegrants market consists of sales of co-processed superdisintegrants, polymer-based superdisintegrants, and cross-linked superdisintegrants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.